How to Buy Verrica Pharmaceuticals Stock
Verrica Pharmaceuticals Inc
Verrica Pharmaceuticals Inc. , a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States.
Verrica Pharmaceuticals stock last closed at $4.39, down 4.98% from the previous day, and has decreased 1.24% in one year. It has overperformed other stocks in the Biotechnology industry by 0.31 percentage points. Verrica Pharmaceuticals stock is currently +33.84% from its 52-week low of $3.28, and -55.3% from its 52-week high of $9.82.
There are currently 17.18M VRCA shares outstanding. The market value of VRCA is $75.41M. In the last 24 hours, 94,000 VRCA shares were traded.
How to Buy Verrica Pharmaceuticals Stock
Wondering how to invest in Verrica Pharmaceuticals stock? Here's how.
- Figure out where to buy Verrica Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Verrica Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your details.
- Analyze Verrica Pharmaceuticals stock: The Verrica Pharmaceuticals ticker symbol is VRCA. Is Verrica Pharmaceuticals stock a good investment? Should you buy shares of VRCA? How do VRCA's underlying business fundamentals look? Do top analysts think Verrica Pharmaceuticals is a good buy? Why has VRCA's stock price moved recently? (Hint: Our stock market research tools can help you figure out if VRCA is a good stock to buy).
- Place your VRCA purchase: Decide if you will purchase VRCA shares at the current market price or use a limit order to purchase VRCA shares at a given price.
- Watch your VRCA position: Create a watchlist to get live updates on your investment in Verrica Pharmaceuticals stock.
Step 1: Figure out where to buy Verrica Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy VRCA stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal information so you can buy VRCA today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start a new brokerage account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on a investment app, your next step is to transfer the money for your investment:
Watch the video below to see the process of depositing funds into your investment account.
Step 4: Analyze Verrica Pharmaceuticals stock
After you have identified the best place to buy Verrica Pharmaceuticals stock, it's very important to evaluate their stock prior to buying, so you truly comprehend the risk as well as the opportunity.
Verrica Pharmaceuticals shares at a glance
VRCA Due Diligence Score
WallStreetZen was created to help average investors perform better fundamental analysis.
You can see all of the due diligence checks on VRCA's stock page.
Is VRCA stock overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge VRCA's true value.
Using relative valuations methods:
- VRCA may be undervalued based on its P/B ratio of 3.05x, relative to Biotechnology industry P/B ratio of 4.64x
You can access more valuation analysis on VRCA's stock here.
VRCA Financial Health Overview
Signs that VRCA is financially healthy:
- VRCA has cash burn of 17627000. It has enough cash and short-term investments to cover this for at least one year.
- Total VRCA debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the VRCA balance sheet.
- There are more short-term assets than long-term liabilities on the VRCA balance sheet.
- VRCA has $30.15M in cash and short term investments. This is enough to cover its annual cash burn of $17.63M.
Signs that VRCA is not financially healthy:
- VRCA has a relatively high debt to equity ratio of 0.91.
- VRCA profit margin has gone up by 9.62 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy Verrica Pharmaceuticals stock
Out of 1 sell side analysts who give forecasts on VRCA, the consensus analyst rating on Verrica Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Verrica Pharmaceuticals stock forecast page.
VRCA Technical Indicators
VRCA Growth Metrics
Last year, VRCA revenue was $35.58M. In the last four year, VRCA's revenue has grown by 31.22% per year. This was faster than the Biotechnology industry average of 29.11%.
Dig into VRCA's earnings and revenue performance here.
Who is buying/selling VRCA?
In the last year, executives and large shareholders at VRCA have bought more shares than they have sold.
John J. Kirby, Interim CFO of VRCA, was the latest VRCA insider to buy. They bought $14,999.71 worth of VRCA stock on Nov 25, 2025.
Get more info about who owns VRCA stock here.
Does VRCA provide a stable income stream?
No, Verrica Pharmaceuticals doesn't provide an income stream by paying out dividends.
VRCA Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your VRCA purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, place a limit order.
Press the Open button and your broker will execute the order.
If you require more help investing in stocks on eToro, click the how to video below:
Step 6: Watch your VRCA position
Now that you own some shares in VRCA, you'll want to keep up with your shares.
Make a watchlist to monitor your VRCA stock.
VRCA Feed
How to Buy Stock in Verrica Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Verrica Pharmaceuticals:
- Figure out where to buy Verrica Pharmaceuticals stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Verrica Pharmaceuticals stock
- Place your VRCA purchase
- Watch your VRCA position
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Verrica Pharmaceuticals, add VRCA to your watchlist below.
Other Stock Buying Guides You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.